The Role of Frozen Section in Evaluating Mediastinal Nodular Lesions Synchronous to Lung Carcinoma

Omron Vitaux^*
*Correspondence: Omron Vitaux, Department of Medical Sciences, Jerash University, Jerash 26110, Jordan, Email:

Introduction

Lung carcinoma is one of the most common and lethal cancers worldwide. It is often diagnosed at an advanced stage, with metastasis occurring to distant sites, including the mediastinum. The mediastinal nodular lesions synchronous to lung carcinoma present significant diagnostic and therapeutic challenges for clinicians and pathologists. The mediastinum, located centrally within the chest, is a complex region that contains vital structures such as the heart, large blood vessels, esophagus, trachea and major bronchi. As a result, mediastinal involvement by cancer is often associated with a poor prognosis. The diagnostic evaluation of mediastinal nodules often includes imaging studies like Computed Tomography (CT) and Positron Emission Tomography (PET), followed by biopsy procedures such as mediastinoscopy, transthoracic needle biopsy, or endobronchial ultrasound. Once a biopsy is performed, the diagnosis can be confirmed histologically and frozen section analysis has emerged as an invaluable tool in providing real-time, intraoperative insights into the nature of mediastinal lesions synchronous to lung carcinoma. Frozen section analysis is a rapid tissue processing technique that allows pathologists to examine a sample of tissue in a matter of minutes during surgery. This technique can be crucial in determining whether a mediastinal nodular lesion is benign or malignant and whether it is primary or metastatic in relation to the lung carcinoma. The purpose of this article is to explore the role of frozen section in the evaluation of mediastinal nodular lesions synchronous to lung carcinoma, examining its effectiveness, clinical relevance and limitations [1].

Description

The mediastinum is anatomically divided into three regions: the anterior, middle and posterior mediastinum. The anterior mediastinum contains structures such as the thymus, fat, lymph nodes and blood vessels; the middle mediastinum houses the heart, pericardium and major bronchi; and the posterior mediastinum contains the esophagus and spinal cord. Mediastinal lesions can arise from any of these structures and when these lesions are seen synchronously with lung carcinoma, they can pose diagnostic and prognostic challenges. Mediastinal nodules seen in conjunction with lung carcinoma can either represent metastatic disease or be primary mediastinal tumors. Metastatic lesions are more commonly seen in the mediastinum in patients with advanced lung carcinoma. The involvement of lymph nodes in the mediastinal region is often indicative of a poor prognosis, as it is associated with advanced-stage disease. However, primary mediastinal tumors, such as lymphoma, thymoma and germ cell tumors, can also present as nodular lesions in the mediastinum. Given the importance of distinguishing between these two possibilities-metastatic vs. primary tumor-early and accurate diagnosis is critical for the formulation of an appropriate treatment plan. Frozen section, or intraoperative frozen section examination, is a technique in which tissue samples obtained during surgery are rapidly frozen, sectioned and examined under a microscope. This provides immediate diagnostic information that can guide surgical decision-making in real time. The tissue sample is typically embedded in a cryostat, frozen to extremely low temperatures and then cut into thin slices for histological evaluation. The pathologist can rapidly examine the tissue, providing a preliminary diagnosis within minutes [2]. The utility of frozen section in evaluating mediastinal lesions synchronous with lung carcinoma is multifaceted. In patients with lung carcinoma, especially Non-Small Cell Lung Cancer (NSCLC), the presence of mediastinal nodular lesions can be a sign of either direct extension of the lung tumor or lymphatic spread to regional mediastinal lymph nodes. Accurate staging is crucial in determining the treatment approach, which may involve surgery, radiation therapy, chemotherapy, or palliative care. In this context, frozen section analysis can be invaluable. It allows for the rapid assessment of suspicious mediastinal nodules or lymph nodes during procedures such as mediastinoscopy, thoracotomy, or video-assisted thoracoscopic surgery (VATS). If a nodular lesion is found to be metastatic at the time of surgery, it can significantly alter the surgical approach. For instance, if a lesion is confirmed as metastatic from the lung carcinoma, the surgeon may avoid performing a resection of the affected lymph node or proceed with a more extensive lymph node dissection [3]. Frozen section analysis provides important real-time data during mediastinal surgery. The speed of diagnosis allows for immediate surgical decision-making, such as whether to perform a complete resection or whether the lesion should be biopsied for further evaluation. In addition to its diagnostic value, frozen section can guide the surgeon in determining the extent of the surgical procedure, helping to tailor treatment strategies based on the nature of the mediastinal lesion. In the context of lung carcinoma, the presence of mediastinal nodules is a key factor in staging the disease. The accurate identification of nodal metastasis is crucial for determining whether the patient is a candidate for surgical resection. For example, if mediastinal lymph nodes are involved, the tumor may be classified as Stage III, which typically precludes surgical resection and may indicate the need for chemoradiotherapy. If, on the other hand, the nodular lesion is benign or represents a primary mediastinal tumor unrelated to the lung carcinoma, a different surgical approach may be warranted. Frozen section plays an important role in mediastinal staging, especially in situations where there is uncertainty about the nature of the lesion. This is particularly important when the clinical presentation is ambiguous and imaging studies fail to provide a clear distinction between a benign and malignant lesion. By providing a rapid diagnosis, frozen section helps to avoid unnecessary delays in treatment and it reduces the likelihood of incomplete or inappropriate surgical interventions [4,5].

Conclusion

Frozen section analysis plays a crucial role in the intraoperative evaluation of mediastinal nodular lesions synchronous to lung carcinoma. By providing rapid diagnostic information, it enables surgeons to make timely decisions during surgery, potentially altering the course of treatment for patients with lung cancer. Despite its limitations, including the potential for sampling error and the need for confirmation with permanent histology, the technique remains an essential tool in the staging and management of mediastinal lesions in the context of lung carcinoma. Given the complexities of mediastinal anatomy and the challenges in distinguishing between metastatic and primary tumors, frozen section analysis provides an invaluable service by assisting clinicians in making critical decisions regarding treatment. As diagnostic technologies and surgical techniques continue to evolve, the role of frozen section in managing mediastinal nodular lesions synchronous to lung carcinoma will undoubtedly remain a key component of clinical practice, helping to guide the optimal management of these challenging cases.

Acknowledgment

None

Conflict of Interest

None

References

1. Rossi, Giulio, Giuseppe Pelosi, Paolo Graziano and Mattia Barbareschi, et al. "A reevaluation of the clinical significance of histological subtyping of non-small-cell lung carcinoma: Diagnostic algorithms in the era of personalized treatments." Int J Surg Pathol 17 (2009): 206-218.

Google Scholar, Crossref, Indexed at

2. Travis, William D., Elizabeth Brambilla, H. Konrad Muller-Hermelink and Curtis C. Harris. "World Health Organization classification of tumours." Pathology and genetics of tumours of the lung, pleura, thymus and heart 10 (2004): 179-84.

Google Scholar